Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Intravenous albumin shortens the duration of hospitalization for patients with hypoalbuminemia and bleeding peptic ulcers: a pilot study.

Cheng HC, Chang WL, Chen WY, Tsai YC, Yeh YC, Sheu BS.

Dig Dis Sci. 2013 Nov;58(11):3232-41. doi: 10.1007/s10620-013-2821-8. Epub 2013 Aug 11.

PMID:
23934414
2.

Seven-day intravenous low-dose omeprazole infusion reduces peptic ulcer rebleeding for patients with comorbidities.

Cheng HC, Chang WL, Yeh YC, Chen WY, Tsai YC, Sheu BS.

Gastrointest Endosc. 2009 Sep;70(3):433-9. doi: 10.1016/j.gie.2009.01.041. Epub 2009 Jun 5.

PMID:
19500787
3.

Double oral esomeprazole after a 3-day intravenous esomeprazole infusion reduces recurrent peptic ulcer bleeding in high-risk patients: a randomised controlled study.

Cheng HC, Wu CT, Chang WL, Cheng WC, Chen WY, Sheu BS.

Gut. 2014 Dec;63(12):1864-72. doi: 10.1136/gutjnl-2013-306531. Epub 2014 Mar 21.

PMID:
24658598
4.

Gastrointestinal bleeding and transfusion strategies in patients with hypoalbuminemia.

Karaahmet F, Coban S, Yuksel I.

Dig Dis Sci. 2014 Feb;59(2):493. doi: 10.1007/s10620-013-2997-y. Epub 2014 Jan 3. No abstract available.

PMID:
24385010
5.

Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion.

Cheng HC, Chuang SA, Kao YH, Kao AW, Chuang CH, Sheu BS.

Hepatogastroenterology. 2003 Nov-Dec;50(54):2270-3.

PMID:
14696515
6.
7.

Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers.

Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, Chan FK, Ng EK, You JH, Lee CW, Chan AC, Chung SC.

N Engl J Med. 2000 Aug 3;343(5):310-6.

8.

Intravenous esomeprazole: a pharmacoeconomic profile of its use in the prevention of recurrent peptic ulcer bleeding.

Keating GM.

Pharmacoeconomics. 2011 Jun;29(6):535-43. doi: 10.2165/11207430-000000000-00000. Review.

PMID:
21568358
9.
10.

Pantoprazole infusion as adjuvant therapy to endoscopic treatment in patients with peptic ulcer bleeding: prospective randomized controlled trial.

Zargar SA, Javid G, Khan BA, Yattoo GN, Shah AH, Gulzar GM, Sodhi JS, Mujeeb SA, Khan MA, Shah NA, Shafi HM.

J Gastroenterol Hepatol. 2006 Apr;21(4):716-21.

PMID:
16677158
11.

Oral or intravenous proton pump inhibitor in patients with peptic ulcer bleeding after successful endoscopic epinephrine injection.

Tsai JJ, Hsu YC, Perng CL, Lin HJ.

Br J Clin Pharmacol. 2009 Mar;67(3):326-32. doi: 10.1111/j.1365-2125.2008.03359.x. Epub 2008 Dec 10.

14.

Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial.

Sung JJ, Barkun A, Kuipers EJ, Mössner J, Jensen DM, Stuart R, Lau JY, Ahlbom H, Kilhamn J, Lind T; Peptic Ulcer Bleed Study Group.

Ann Intern Med. 2009 Apr 7;150(7):455-64. Epub 2009 Feb 16.

PMID:
19221370
15.

Comparison of intravenous pantoprazole with intravenous ranitidine in peptic ulcer bleeding.

Demetrashvili ZM, Lashkhi IM, Ekaladze EN, Kamkamidze GK.

Georgian Med News. 2013 Oct;(223):7-11.

PMID:
24214585
16.

Efficacy of an intravenous proton pump inhibitor after endoscopic therapy with epinephrine injection for peptic ulcer bleeding in patients with uraemia: a case-control study.

Tseng GY, Fang CT, Lin HJ, Yang HB, Tseng GC, Wang PC, Liao PC, Cheng YT, Huang CH.

Aliment Pharmacol Ther. 2009 Aug 15;30(4):406-13. doi: 10.1111/j.1365-2036.2009.04049.x. Epub 2009 May 26.

17.

Hypoalbuminemia is a predictor of mortality and rebleeding in peptic ulcer bleeding under proton pump inhibitor use.

Cheng HC, Yang EH, Wu CT, Wang WL, Chen PJ, Lin MY, Sheu BS.

J Formos Med Assoc. 2017 Jul 24. pii: S0929-6646(17)30358-3. doi: 10.1016/j.jfma.2017.07.006. [Epub ahead of print]

18.

Poor responders to intravenous omeprazole in patients with peptic ulcer bleeding.

Hsieh YH, Lin HJ, Tseng GY, Perng CL, Wang K, Lo WC, Chang FY, Lee SD.

Hepatogastroenterology. 2004 Jan-Feb;51(55):316-9.

PMID:
15011893
19.

Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis.

Liang CM, Lee JH, Kuo YH, Wu KL, Chiu YC, Chou YP, Hu ML, Tai WC, Chiu KW, Hu TH, Chuah SK.

BMC Gastroenterol. 2012 Mar 28;12:28. doi: 10.1186/1471-230X-12-28.

20.

A comparison of oral omeprazole and intravenous cimetidine in reducing complications of duodenal peptic ulcer.

Khoshbaten M, Fattahi E, Naderi N, Khaleghian F, Rezailashkajani M.

BMC Gastroenterol. 2006 Jan 11;6:2.

Supplemental Content

Support Center